BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14572203)

  • 1. More on the reliability of the microparticle enzyme immunoassay (MEIA) for therapeutic tacrolimus monitoring.
    Hermida J; Tutor JC
    Clin Lab; 2003; 49(9-10):471-4. PubMed ID: 14572203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
    Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloned enzyme donor immunoassay tacrolimus assay compared with high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in liver and renal transplant recipients.
    Westley IS; Taylor PJ; Salm P; Morris RG
    Ther Drug Monit; 2007 Oct; 29(5):584-91. PubMed ID: 17898648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the hematocrit and its correction on the relationship between blood tacrolimus concentrations obtained using the microparticle enzyme immunoassay (MEIA) and enzyme multiplied immunoassay technique (EMIT).
    Bouzas L; Ortega FJ; Casado P; Arranz MI; Carcas A; Tutor JC
    Clin Lab; 2007; 53(9-12):591-6. PubMed ID: 18257466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of renal transplantation using liquid chromatographic monitoring of tacrolimus.
    Borrows R; Chusney G; Loucaidou M; James A; Stichbury J; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
    Ther Drug Monit; 2006 Apr; 28(2):269-73. PubMed ID: 16628143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of hematocrit interference in the tacrolimus II microparticle enzyme immunoassay: a tentative approach.
    Hermida J; Fernández MC; Tutor JC
    Clin Lab; 2005; 51(1-2):43-5. PubMed ID: 15719703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
    Akbas SH; Ozdem S; Caglar S; Tuncer M; Gurkan A; Yucetin L; Senol Y; Demirbas A; Gultekin M; Ersoy FF; Akaydin M
    Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
    Ju MK; Chang HK; Kim HJ; Huh KH; Ahn HJ; Kim MS; Kim SI; Kim YS
    Transplant Proc; 2008 Dec; 40(10):3673-8. PubMed ID: 19100463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients.
    Akbas SH; Yavuz A; Tuncer M; Yurdakonar E; Akcit F; Gurkan A; Demirbas A; Gultekin M; Ersoy F; Akaydin M
    Transplant Proc; 2004; 36(1):86-8. PubMed ID: 15013308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.
    Marubashi S; Nagano H; Kobayashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Monden M; Doki Y; Mori M
    J Clin Pharmacol; 2010 Jun; 50(6):705-9. PubMed ID: 20097937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evaluation of the new TACR flex method versus MEIA method in the therapeutic monitoring of tacrolimus in organ transplantation.
    Bachetoni A; Mariani P; D'Alessandro M; Baiano V; Appodia C; Collepardo D; Berloco P
    Transplant Proc; 2007; 39(6):2008-9. PubMed ID: 17692678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus monitoring in renal transplantation: a comparison between high-performance liquid chromatography and immunoassay.
    Borrows R; Chusney G; Loucaidou M; Singh S; James A; Stichbury J; Van Tromp J; Cairns T; Griffith M; Hakim N; McLean A; Palmer A; Papalois V; Taube D
    Transplant Proc; 2005 May; 37(4):1733-5. PubMed ID: 15919448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
    J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of blood tacrolimus concentrations in liver and kidney transplant recipients using ACMIA and MEIA immunoassays.
    Freire A; Hermida J; Tutor JC
    Ups J Med Sci; 2008; 113(1):103-10. PubMed ID: 18521804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus.
    Braun F; Lorf T; Schütz E; Christians U; Grupp C; Sattler B; Canelo R; Sewing KF; Armstrong VW; Oellerich M; Ringe B
    Transplant Proc; 1996 Dec; 28(6):3175-6. PubMed ID: 8962231
    [No Abstract]   [Full Text] [Related]  

  • 16. High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants.
    Salm P; Taylor PJ; Clark A; Balderson GA; Grygotis A; Norris RL; Lynch SV; Shaw LM; Pond SM
    Ther Drug Monit; 1997 Dec; 19(6):694-700. PubMed ID: 9421113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the reintroduced MEIA assay with HPLC-MS/MS for the determination of whole-blood sirolimus from transplant recipients.
    Morris RG; Salm P; Taylor PJ; Wicks FA; Theodossi A
    Ther Drug Monit; 2006 Apr; 28(2):164-8. PubMed ID: 16628125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a new immunoassay to measure sirolimus blood concentrations compared to a tandem mass-spectrometric chromatographic analysis.
    Fillée C; Mourad M; Squifflet JP; Malaise J; Lerut J; Reding R; Borghgraef P; Vanbinst R; Wallemacq PE
    Transplant Proc; 2005; 37(6):2890-1. PubMed ID: 16182845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay.
    Wallemacq P; Goffinet JS; O'Morchoe S; Rosiere T; Maine GT; Labalette M; Aimo G; Dickson D; Schmidt E; Schwinzer R; Schmid RW
    Ther Drug Monit; 2009 Apr; 31(2):198-204. PubMed ID: 19258928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatography versus immunoassay for the measurement of sirolimus: comparison of two methods.
    Zochowska D; Bartłomiejczyk I; Kamińska A; Senatorski G; Paczek L
    Transplant Proc; 2006; 38(1):78-80. PubMed ID: 16504669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.